X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (202) 202
female (151) 151
index medicus (145) 145
male (141) 141
middle aged (138) 138
adult (132) 132
hematology (120) 120
aged (105) 105
oncology (87) 87
adolescent (69) 69
cancer (60) 60
aged, 80 and over (55) 55
treatment outcome (54) 54
prognosis (47) 47
young adult (47) 47
multiple myeloma (40) 40
chemotherapy (36) 36
dendritic cells (36) 36
leukemia (35) 35
original (31) 31
original article (31) 31
antineoplastic combined chemotherapy protocols - therapeutic use (29) 29
care and treatment (29) 29
disease-free survival (29) 29
transplantation (29) 29
immunotherapy (28) 28
medicine & public health (28) 28
retrospective studies (28) 28
hemic and lymphatic diseases (27) 27
hematology, oncology and palliative medicine (26) 26
survival (25) 25
dendritic cells - immunology (24) 24
medicine, general & internal (23) 23
acute myeloid leukemia (21) 21
acute myeloid-leukemia (20) 20
genetic aspects (20) 20
mutation (20) 20
risk (20) 20
leukemia, myeloid, acute - genetics (19) 19
medical colleges (19) 19
survival rate (19) 19
therapy (19) 19
analysis (18) 18
expression (18) 18
follow-up studies (18) 18
risk factors (18) 18
diagnosis (17) 17
research (17) 17
stem cells (17) 17
survival analysis (17) 17
t cells (17) 17
antineoplastic agents - therapeutic use (16) 16
chronic myeloid leukemia (16) 16
hematopoietic stem cell transplantation (16) 16
medicine, research & experimental (16) 16
recurrence (16) 16
remission induction (16) 16
의학일반 (16) 16
differentiation (15) 15
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (15) 15
chronic myelogenous leukemia (14) 14
genotype (14) 14
imatinib mesylate (14) 14
lymphoma (14) 14
vaccination (14) 14
aml (13) 13
apoptosis (13) 13
azacitidine (13) 13
bortezomib (13) 13
cell biology (13) 13
hematopoietic stem cells (13) 13
imatinib (13) 13
leukemia, myeloid, acute - therapy (13) 13
multiple myeloma - drug therapy (13) 13
myelodysplastic syndromes (13) 13
t-cells (13) 13
t-lymphocytes, cytotoxic - immunology (13) 13
transplantation, homologous (13) 13
acute myelogenous leukemia (12) 12
cell line, tumor (12) 12
dexamethasone (12) 12
immunology (12) 12
in-vitro (12) 12
multiple myeloma - pathology (12) 12
mutations (12) 12
phenotype (12) 12
polymorphism, genetic (12) 12
polymorphism, single nucleotide (12) 12
research article (12) 12
time factors (12) 12
antimitotic agents (11) 11
antineoplastic agents (11) 11
cytogenetics (11) 11
genetic predisposition to disease (11) 11
genomics (11) 11
leukemia, myelogenous, chronic, bcr-abl positive - genetics (11) 11
multiple myeloma - immunology (11) 11
animals (10) 10
antineoplastic combined chemotherapy protocols - administration & dosage (10) 10
biochemistry & molecular biology (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 2014, Volume 506, Issue 7488, pp. 328 - 333
In acute myeloid leukaemia (AML), the cell of origin, nature and biological consequences of initiating lesions, and order of subsequent mutations remain poorly... 
HETEROGENEITY | PATHOGENESIS | ORIGIN | METASTASIS | MULTIDISCIPLINARY SCIENCES | ARCHITECTURE | DNA METHYLTRANSFERASE | CLONAL EVOLUTION | ACUTE MYELOID-LEUKEMIA | DNMT3A MUTATIONS | DIFFERENTIATION | Clone Cells - cytology | Neoplasm Transplantation | Neoplastic Stem Cells - cytology | Neoplastic Stem Cells - drug effects | Humans | Hematopoietic Stem Cells - pathology | DNA (Cytosine-5-)-Methyltransferases - metabolism | Heterografts | Neoplastic Stem Cells - metabolism | T-Lymphocytes - metabolism | Hematopoiesis | Cell Division | Leukemia, Myeloid, Acute - drug therapy | Neoplastic Stem Cells - pathology | Female | Cell Differentiation | T-Lymphocytes - pathology | Nuclear Proteins - genetics | Hematopoietic Stem Cells - drug effects | Leukemia, Myeloid, Acute - pathology | Isocitrate Dehydrogenase - genetics | Hematopoietic Stem Cells - metabolism | Mice, SCID | Mutation - genetics | Clone Cells - metabolism | Remission Induction | Cell Lineage | DNA (Cytosine-5-)-Methyltransferases - genetics | Animals | Clone Cells - pathology | Leukemia, Myeloid, Acute - diagnosis | Hematopoietic Stem Cells - cytology | Mice, Inbred NOD | Mice | Drug Resistance, Neoplasm - drug effects | Leukemia, Myeloid, Acute - genetics | Acute leukemia | Genetic aspects | Diagnosis | Identification and classification | Hematopoietic stem cells
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 1819 - 1819
Multiple myeloma (MM) is the second-most-common hematologic malignancy, and develops from clonal malignant plasma cells within bone marrow. Despite tremendous... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 5525 - 5525
Purpose : Many clinical trials have been conducted to prove the efficiacy of the new agrent or treatment regimen in patients with multiple myeloma (MM), but... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4236 - 4236
Abstract Bone marrow involvement (BMI) has important clinical implication in diffuse large B cell lymphoma (DLBCL) as a component of staging and International... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 3194 - 3194
Abstract Background: The therapeutic efficacy of dendritic cell (DC)-based immunotherapy may be potentiated in combination with other anticancer therapies that... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 4263 - 4263
Background: Hypomethylating agents (HMAs) are used to treat patients with lower-risk myelodysplastic syndrome (LR-MDS) relapsing after the use of hematopoietic... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 2329 - 2329
Introduction Terminally differentiated effector memory (TEMRA) cells have been recent revealed as sub-population of CD8 T cells, and they have been expected to... 
Journal Article
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 10/2019, Volume 19, Issue 10, pp. e163 - e163
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 4642 - 4642
Abstract [Background] Erythropoiesis stimulating agents (ESAs) are used as standard treatment for anemia in patients with myelodysplastic syndromes (MDS) of... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4361 - 4361
Abstract Introduction Myelodysplastic syndrome (MDS) is a heterogeneous group of myeloid disorder characterized by defective bone marrow (BM) hematopoiesis... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4483 - 4483
Abstract Purpose : This study evaluated the prognostic role of 18F-FDG PET/CT at baseline in patients with newly diagnosed multiple myeloa (MM) and evaluated... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1632 - 1632
Abstract Purpose: The clinical role of 18F-fluorodeoxyglucose (FDG)-positron emission tomography-computed tomography (PET/CT) in performing upfront high-dose... 
Journal Article
BMC Cancer, ISSN 1471-2407, 07/2018, Volume 18, Issue 1
A relatively high proportion of patients diagnosed with primary CNS lymphoma will experience recurrent disease, yet therapy options are limited in salvage... 
Usage | Bendamustine | Analysis | Therapeutics | Dosage and administration | Non-Hodgkin's lymphomas | Diagnosis | Research | Drug therapy | Pharmacokinetics | Homeopathy | Materia medica and therapeutics
Journal Article
International Journal of Cancer, ISSN 0020-7136, 05/2017, Volume 140, Issue 10, pp. 2364 - 2374
Treatment of acute myeloid leukemia (AML) largely depends on chemotherapy, but current regimens have been unsatisfactory for long-term remission. Although... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 1623 - 1623
Abstract Introduction: The present study attempted to build a single nucleotide polymorphism (SNP)-based risk model for predicting overall survival (OS) and... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 1643 - 1643
Background The recent discontinuation clinical trials have demonstrated that IM discontinuation can be employed based on clinical study in patients who had... 
Journal Article
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 10/2019, Volume 19, Issue 10, pp. e189 - e190
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.